Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy Versus Surgery Alone in Resectable Esophageal Squamous Cell Carcinoma
Phase of Trial: Phase II/III
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Cisplatin (Primary) ; Nimotuzumab (Primary) ; Paclitaxel (Primary)
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 05 Apr 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 05 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.
- 05 Apr 2017 Status changed from recruiting to suspended.